RxDoctor Payments Data

Talia Fragello, PA

Physician Assistant · Bethel Park, PANPI 1073653796

Payments from drug & device makers

$2,664in general payments, 2019–2025

Across 172 payments — averaging $15.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$555
  • Abbott$530
  • Dexcom, Inc.$438
  • Novo Nordisk$324
  • AbbVie$227
  • Tandem Diabetes Care, Inc.$175
  • plus $414 from 10 others
$1,864in research payments, 2019–2025

Across 4 payments — averaging $466.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Dexcom, Inc.$2K

What the payments were for

  • Food & beverage$2,664100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,664 in reported general payments places this provider in the 85th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$15,049
Medicare patients
98
Services billed
319

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide72$93,619
OzempicSemaglutide57$81,652
TrulicityDulaglutide16$27,430
JardianceEmpagliflozin22$23,002
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog22$18,720
Tresiba Flextouch U-100Insulin Degludec11$16,750
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog11$14,826
Lantus SolostarInsulin Glargine,hum.Rec.Anlog78$13,424
Humalog Kwikpen U-100Insulin Lispro28$12,623
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/712$11,120
Novolog FlexpenInsulin Aspart29$10,580
Tresiba Flextouch U-200Insulin Degludec12$9,546
JanuviaSitagliptin Phosphate13$8,394
NovologInsulin Aspart14$6,965
Praluent PenAlirocumab12$5,753

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity, Humalog$555$124,434101 claims
Novo NordiskOzempic, Novolog$324$88,61771 claims
AbbVieSynthroid, Armour Thyroid$227$6,857112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Bethel Park

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →